CrushSCI.com
217.5Average days
197Median days
126Fastest days
407Longest days
1422025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

200 days

Landscape of hereditary angioedema in China: A multicenter cross-sectional questionnaire survey

Authors
Yingyang Xu; Wei Chen; Timothy Craig; Shan Deng; Yinshi Guo; Henry H. Li; Philip H. Li; Yingnan Li; Ruiling Liu; Han Ma; Yan Ma; Chunrui Shi; Huichun Su; Yuemei Sun; Siqing Wang; Yan Wang; Qingyu Wei; Lingying Wu; Yongmei Yu; Dan Zeng; Huanping Zhang; Rongfei Zhu; Yuxiang ZhiShow moreShow less
Affiliations
Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Department of Allergy, Xing'an League People's Hospital, Inner Mongolia 137400, China; Department of Medicine, Pediatrics, and Biomedical Sciences, Penn State Health Allergy, Asthma, and Immunology, Hershey, Pennsylvania, USA; Center of Allergy and Clinical Immunology, Vinmec International Hospital Times City & VinUni Institute of Immunology, VinUniversity, Hanoi, Viet Nam; Department of Allergy, The Second Affiliated Hospital of Dalian Medical University, Dalian 116000, China; Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China; Institute for Asthma and Allergy, Chevy Chase, Maryland, 20815, USA; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China; Department of Rheumatology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Department of Allergy, Tianjin Medical University General Hospital, Tianjin 300052, China; Department of Dermatology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China; Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Department of Dermatology and Venereology, The First Hospital of Lanzhou University, Lanzhou 730000, China; Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou 350001, China; Department of Allergy, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264000, China; Department of Allergy, Henan Provincial People's Hospital, Zhengzhou 450003, China; Department of Otolaryngology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China; Department of Allergy, Shengjing Hospital of China Medical University, Shenyang 110004, China; Department of Allergy, The Third People's Hospital of Datong, Datong 037000, China; Department of Otorhinolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China; Department of Allergy, Chongqing General Hospital, Chongqing University, Chongqing 401147, China; Department of Allergy, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China; Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaShow moreShow less
Source PDF DOI Publisher page
292 days

Olive allergens under the microscope: Ole e 7 and Ole e 9 sensitization does not increase symptom severity or adverse reactions to subcutaneous allergen immunotherapy

Authors
Manuel Alcántara Villar; Alicia López Guerrero; Miriam Bermúdez Bejarano; Cristina Ruiz González; Patricia de Manueles Tabliega; Guillermo Salamanca FernándezShow moreShow less
Affiliations
Allergology Unit, Jaén University Hospital, Jaén, Spain; Medical Affairs Unit, LETI Pharma, Madrid, SpainShow moreShow less
Source PDF DOI Publisher page
235 days

Clinical utility of Oriton IgE CHEMIPHAR™ for predicting skin prick test positivity in patients with allergic airway diseases

Authors
Erika Naito; Tomoyuki Soma; Kazuyuki Nakagome; Ryu Sekiya; Yoshitaka Uchida; Takehito Kobayashi; Makoto NagataShow moreShow less
Affiliations
Department of Respiratory Medicine, Saitama Medical University, Iruma-gun, Saitama 350-0495, Japan; Allergy Center, Saitama Medical University, Iruma-gun, Saitama 350-0495, JapanShow moreShow less
Source PDF DOI Publisher page
171 days

Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma

Authors
Wenhua Ming; Yang Zhou; Tingting Liu; Hongtian Wang; Xueyan Wang; Tingting MaShow moreShow less
Affiliations
Allergy Department, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China; Allergy Research Institute, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China; Beijing Institute of Medical Device Testing, Beijing, 101111, ChinaShow moreShow less
Source PDF DOI Publisher page
197 days

Mast cell activation syndrome: Global perspectives from a World Allergy Organization survey on knowledge, diagnosis, and access to care

Authors
Pedro Giavina-Bianchi; Mara Giavina-Bianchi; Mário Morais-Almeida; Iván Álvarez-Twose; Jonathan A. Bernstein; Sigurd Broesby-Olsen; Mariana Castells; Theo Gulen; Karin Hartmann; Alberto Orfao; Thanai Pongdee; Tiago Azenha Rama; Frank Siebenhaar; Gilda Varricchi; Bryan L. Martin; Alessandro Fiocchi; Gary Wing-Kin Wong; Ignacio J. Ansotegui; Cem AkinShow moreShow less
Affiliations
Clinical Immunology and Allergy Division, School of Medicine, Universidade de São Paulo, Brazil; Instituto de Investigação Em Imunologia, São Paulo, Brazil; Hospital Israelita Albert Einstein, São Paulo, Brazil; Centro de Alergia, Hospital CUF Descobertas. Lisboa, Portugal; Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Spain; Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Toledo, Spain; University of Cincinnati Medical Center, Cincinnati, OH, United States; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark; Brigham and Women's Hospital, Mastocytosis Center, Division of Allergy and Immunology, Harvard Medical School, United States; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institute, Stockholm, Sweden; Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Switzerland; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland; Department of Biomedicine, University Hospital Basel and University of Basel, Switzerland; Cancer Research Center (IBMCC, CSIC-USAL), Cytometry Service (NUCLEUS), Department of Medicine, University of Salamanca (Universidad de Salamanca), Spain; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Mayo Clinic, Department of Medicine, Section of Allergy and Immunology, Rochester, MN, United States; Serviço de Imunoalergologia, Unidade Local de Saúde de Matosinhos, Portugal; Serviço de Imunologia Básica e Clínica, Faculdade de Medicina da Universidade Do Porto, Portugal; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany; Department of Translational Medical Sciences, University of Naples Federico II, Center for Basic and Clinical Immunology Research (CISI), World Allergy Oganization (WAO) Center of Excellence (CoE), Italy; Ohio State University, Columbus, OH, United States; Pediatric Hospital Bambino Gesù, Rome, Italy; The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China; Department of Allergy and Immunology, Hospital Quironsalud Bizkaia. Bilbao, Spain; University of Michigan, Department of Medicine, Division of Allergy and Immunology, Ann Arbor, MI, United StatesShow moreShow less
Source PDF DOI Publisher page
165 days

Real-world effectiveness of fluticasone propionate–azelastine nasal spray in moderate-to-severe nonallergic and perennial allergic rhinitis

Authors
Piyaporn Chokevittaya; Noraworn Jirattikanwong; Phanu Prasankiattirach; Chamard Wongsa; Norapat Limsirorat; Pasiri Jungsanguanpornsuk; Mongkhon Sompornrattanaphan; Kawita Atipas; Navarat Kasemsuk; Dichapong Kanjanawasee; Triphoom Suwanwech; Pongsakorn Tantilipikorn; Wannada Laisuan; Phichayut Phinyo; Jonathan A. Bernstein; Torpong ThongngarmShow moreShow less
Affiliations
Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Biomedical Informatics and Clinical Epidemiology (BioCE), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Division of Rhinology and Allergy, Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does World Allergy Organization Journal take to review a manuscript?

As of 2026-11-13, CrushSCI has 15 complete review records for World Allergy Organization Journal. The fastest paper went from submission to acceptance in 126 days (ATP/P2X7 signaling as a potential predictive biomarker for early recurrence of nasal polyps: Correlation with inflammasome activation and epithelial barrier dysfunction, received 2026-04-06, accepted 2026-08-10); the slowest took 407 days. The average is 217.5 days and the median is 197 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.